VANI - NASDAQ

Vivani Medical, Inc.

VANI·NASDAQ

$1.28

+0.39%

HealthcareMedical - Devices

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$75.92M

EPS-0.4300

P/E Ratio-2.99

Earnings Date08/12/2026

vani

Net Cash Provided by Financing Activities

Last Annual Value

23.27M

3-Year CAGR

-28%

5-Year CAGR

20%

10-Year CAGR

24%

Adjust for Inflation

Vivani Medical, Inc. Competitors Analysis of Net Cash Provided by Financing Activities

VANI · NASDAQ

Company	Net Cash Provided by Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Vivani Medical, Inc. NASDAQ:VANI	23.27M	459.3%	14.9%	1.3%
Microbot Medical Inc. NASDAQ:MBOT	86.24M	136.0%	N/A	39.5%
Clene Inc. NASDAQ:CLNN	11.52M	-35.1%	-15.7%	N/A
CervoMed Inc. NASDAQ:CRVO	46.40M	60.9%	6.9%	38.2%
MindWalk Holdings Corp. NASDAQ:HYFT	14.89M	N/A	-19.3%	N/A
Pulmonx Corporation NASDAQ:LUNG	903.00K	-65.2%	-27.5%	N/A
Spectral AI, Inc. NASDAQ:MDAI	20.12M	73.6%	7.6%	N/A
XBiotech Inc. NASDAQ:XBIT	-10.25M	N/A	N/A	N/A
Immix Biopharma, Inc. NASDAQ:IMMX	107.39M	90.8%	41.6%	N/A
FONAR Corporation NASDAQ:FONR	-7.47M	N/A	N/A	N/A
Quipt Home Medical Corp. NASDAQ:QIPT	-7.76M	N/A	N/A	N/A

Vivani Medical, Inc. Fair Value Envelope

VANI · NASDAQ

Our analysis suggests that VANI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.285, this represents a potential HIDDEN relative to our calculated worth for Vivani Medical, Inc..

HIDDEN

Intrinsic Value

Current Price: $1.285

Related Guides

Blog Categories

Continue your VANI research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.